two major have already occurred... Sanofi investing awhopping 700 million
dollars at $ 80 per share... and Gnezyme adding another 35 millions shares
at $ 68 per share just 2 weeks ago... I think at these levels owning this stock is
a NO brainer... she may go down a bit more along with the bio tech dump.. but
when the selling is over.. she can bounce back violently.. I see $ 90++ by year
end easy... and $ 125 within 2-3 years... almost 250% return from here..
risk reward at these levels is fantastic..... own it without ANY worries.. add more
if she dips below 50..